These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11178325)

  • 1. [Advances in research on the molecular pathogenesis of the malignant tumours and implications for their early diagnosis and treatment].
    Steffen J
    Med Wieku Rozwoj; 2000; 4(2 Suppl 2):11-25. PubMed ID: 11178325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations and altered expression of the human cancer genes: what they tell us about causes.
    Devereux TR; Risinger JI; Barrett JC
    IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic factors involved in cancer susceptibility].
    Kohno T; Yokota J
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1255-62. PubMed ID: 12146010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relevance of BRCA genetics to prostate cancer pathogenesis and treatment.
    Sundararajan S; Ahmed A; Goodman OB
    Clin Adv Hematol Oncol; 2011 Oct; 9(10):748-55. PubMed ID: 22252577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell-type-specificity of inherited predispositions to tumours: review and hypothesis.
    Bignold LP
    Cancer Lett; 2004 Dec; 216(2):127-46. PubMed ID: 15533589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary carcinoma: pathogenesis and diagnosis].
    Jungck M
    Zentralbl Chir; 2000; 125 Suppl 1():8-11. PubMed ID: 10929639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating germline and somatic data towards a personalized cancer medicine.
    Pujana MA
    Trends Mol Med; 2014 Aug; 20(8):413-5. PubMed ID: 25086750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.
    Horswell S; Matthews N; Swanton C
    Cancer Lett; 2013 Nov; 340(2):220-6. PubMed ID: 23142290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection.
    Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetics and cancer: advances and perspectives].
    Kahn A
    Pathol Biol (Paris); 1995 Mar; 43(3):139-42. PubMed ID: 7675539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and molecular aspects of human multigenerational carcinogenesis.
    Evans HJ
    IARC Sci Publ; 1989; (96):315-33. PubMed ID: 2553599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma.
    Durno C; Aronson M; Bapat B; Cohen Z; Gallinger S
    Gut; 2005 Aug; 54(8):1146-50. PubMed ID: 15845562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing in gastroenterology: Lynch syndrome.
    Grover S; Syngal S
    Best Pract Res Clin Gastroenterol; 2009; 23(2):185-96. PubMed ID: 19414145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers.
    Hopper JL; Jenkins MA; Dowty JG; Dite GS; Apicella C; Keogh L; Win AK; Young JP; Buchanan D; Walsh MD; Rosty C; Baglietto L; Severi G; Phillips KA; Wong EM; Dobrovic A; Waring P; Winship I; Ramus SJ; Giles GG; Southey MC
    Pathology; 2012 Feb; 44(2):89-98. PubMed ID: 22198256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common gene polymorphisms, cancer progression and prognosis.
    Loktionov A
    Cancer Lett; 2004 May; 208(1):1-33. PubMed ID: 15105042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial (hereditary) cancer].
    Maekawa M
    Rinsho Byori; 2002 Nov; Suppl 123():121-30. PubMed ID: 12652799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic pathways in hereditary and sporadic breast cancer.
    Kenemans P; Verstraeten RA; Verheijen RH
    Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment.
    Spizzo R; Rushworth D; Guerrero M; Calin GA
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S313-8. PubMed ID: 19778859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary cancer and its clinical implications: a view.
    Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; De Graaf PW; Derkinderen DJ; Hill FW; Huber J; Klein WR
    Anticancer Res; 1990; 10(2B):489-95. PubMed ID: 2190527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.